Miracil D preferentially inhibited the growth of a deoxyribonucleic acid (DNA) polymerase-deficient Escherichia coli strain. This is taken to indicate that miracil D is capable of altering the DNA of living cells and that it may thereby be a potential mutagen and carcinogen.
Recently, we described (10) a microbiological assay in which a deoxyribonucleic acid (DNA) polymerase-deficient (pol A,-) Escherichia coli strain is used for the detection of potential carcinogens and mutagens. Although the procedure cannot replace screening in animals, it can be used to select "suspicious" substances for further testing. It is reported here that miracil D gives a positive test in this bioassay system.
Miracil D (lucanthone, 1-[2-diethylaminoethylamino]-4-methylthiaxanthone) and hycanthone (1-[2-diethylaminoethylamino]-4-hydroxymethylthiaxanthone) are used in the treatment of schistosomiasis. It was recently shown that these drugs possessed mutagenic potentials, and, because of the correlation in many instances between mutagenesis and carcinogenesis in mammals, it seemed advisable to investigate these effects further.
Thus, it was reported (3) that, although hycanthone was mutagenic for bacteria (Salmonella), miracil D was not; on the other hand, both substances induced mutations in bacteriophage T4 (3) . Miracil D is also weakly mutagenic for drosophila (2) , and it causes achromatic lesions and chromatid breaks in human leukocytes in vitro (2) . In the present report, it is shown that unmodified miracil D preferentially blocks the growth of DNA polymerase-deficient (pol Al-) bacteria (E. coli; Tables 1 and 2 ). This is a property it shares with substances known to alter the DNA of living cells, some of which are known mutagens and carcinogens (Table 1 ; references 10 and 12) .
The basis of this preferential inhibition of pol Al-cells is believed to be the following. Nor- a The procedure used has been described in detail elsewhere (10) . E. coli W3110 thy-(pol A+) and its DNA polymerase-deficient (pol A1-) derivative E. coli p 3478 (1) were grown in medium HA (8) supplemented with thymine (5 jg/ml); 0.1-ml portions of the cultures were spread onto the surface of agar plates of the same composition (7) . When the surface of the agar had dried, sterile disks (6.35 mm in diameter) impregnated with the substance to be tested were deposited onto the surface of the agar and the plates were incubated in the dark for 12 h, whereupon the diameters of the zones of inhibition were measured. Substances known to react with the cellular DNA (e.g., methyl methanesulfonate) as well as drugs which do not react with the cellular DNA (e.g., chloramphenicol) were included in each experiment as "positive" and "negative" controls.
mally, when cellular DNA is damaged by noxious agents, cells attempt to overcome this by various DNA repair systems. Because DNA polymerase I is involved in the DNA repair a Bacteria in medium HA supplemented with 5 ug of thymine per ml (7, 8) were brought to the exponential growth phase at which time portions of the cultures were supplemented with miracil D (10 Mg/ ml). At intervals, portions of each culture were removed, serially diluted, and spread onto the surface of agar plates containing medium HA supplemented with thymine (5 yg/ml; 7). Viable bacteria were enumerated after 18 h of incubation at 37 C.
process (1, 5) , cells (pol A,-) lacking this enzyme are more sensitive than pol A+ cells to the lethal action of such agents (1, 6, 10, 12) . This preferential sensitivity of pol A,-cells for agents which alter cellular DNA was used as the basis of a bioassay for potential mutagens and carcinogens (10) . The fact that miracil D preferentially blocks pol A1-cells may be, therefore, of signifcance.
Both hycanthone and miracil D appear to be frameshift mutagens for bacteriophage T4 (3). Such mutagens usually have the ability to intercalate between DNA base pairs, and presumably thiaxanthones also possess this ability (4) . It is interesting, therefore, that pol A,-cells are also inhibited preferentially by known DNA intercalators, e.g., acridine orange, proflavine, ethidium bromide, chloroquine, and quinacrine (Table 1 ; references 9 and 11). With acridine orange, it was actually shown (11; unpublished data) that the cellular DNA was modified but that normal (pol A+) cells were capable of rapidly repairing the damaged DNA whereas pol A1-cells were incapable of doing so, as a result of which the cells died. Presumably, the lack of mutagenicity of miracil D for Salmonella (3) and the absence of an inhibitory effect on pol A+ cells (Tables 1 and 2) (Tables 1 and 2) .
It would seem, therefore, that the potential genetic and carcinogenic effects of miracil D deserve further evaluation, especially because this drug mimics the effects of acridine orange, a substance which has been shown to be oncogenic (13) . 
